Latest News

SCRT/Chemo Produce Positive Responses in Locally Advanced Rectal Cancer
SCRT/Chemo Produce Positive Responses in Locally Advanced Rectal Cancer

June 3rd 2025

Results from the ShorTrip trial found that SCRT plus chemotherapy regimens showed promising efficacy for patients with locally advanced rectal cancer.

Disitamab Vedotin/Toripalimab/Trastuzumab Yield Responses in G/GEJ Cancer
Disitamab Vedotin/Toripalimab/Trastuzumab Yield Responses in G/GEJ Cancer

June 2nd 2025

EBC-129 was well tolerated, with a safety profile consistent with other MMAE-based ADCs in patients with PDAC and other solid tumors.
EBC-129 Shows Early Activity in Advanced Pancreatic Ductal Adenocarcinoma

June 2nd 2025

Elraglusib Plus Chemo Enhances Survival Vs Chemo Alone in Metastatic PDAC
Elraglusib Plus Chemo Enhances Survival Vs Chemo Alone in Metastatic PDAC

June 1st 2025

Adjuvant Nivolumab Provides Sustained Benefit in Resected Esophageal/GEJ Cancer
Adjuvant Nivolumab Provides Sustained Benefit in Resected Esophageal/GEJ Cancer

June 1st 2025

More News